Nov 03, 2021 / 02:58PM GMT
Jonathan Matthew Aschoff - ROTH Capital Partners, LLC, Research Division - MD & Senior Research Analyst
Good morning, everyone, and welcome to the real fireside chat with Novan CEO, Paula Stafford. I'm your host, Jonathan Aschoff, senior biotechnology analyst at ROTH Capital Partners.
Questions and Answers:
Jonathan Matthew Aschoff - ROTH Capital Partners, LLC, Research Division - MD & Senior Research AnalystAnd first, Paula, would you please give us a little background on how you came to lead Novan?
Paula Brown Stafford - Novan, Inc. - President, CEO & Chairwoman
Well, I came to Novan as a consultant in 2017. I had been at Quintiles, now IQVIA for 31 years and had retired and was doing a little consulting with another pharmaceutical company, and the Board of Directors called and asked me to come in and consult. And then I really kind of fell in love with the company, fell in love with the technology and went to join them as an employee half-time and then became the COO in 2019, and then in 2020, I